|
| | 
|
 | |
        
|  |
|  |
|
| PS: The quotes after 2017-05-12 are still temporary and may have for that reason the Open values wrong until furter updates...
Change to Biogen Idec Inc. Static Chart |
 Biogen Idec Inc. - [Ticker: BIIB] |     | | Last Trade | 315.51 | Last Trade Time | 2017-11-01 - 19:35:00 | | Variation | +3.85 (+1.24%) | Open | 312.75 | | High | 319.95 | Low | 311.57 | | Volume | 1,047,609 | Average Volume (3m) | 0 | | Yield | | Bid / Ask | 315.47 x 300 - 315.59 x 200 | | Former Close | 311.66 | 52 Week Range | [0.00 - 0.00] | | PER | 0.00% | EPS | 0.00 | | Ex-Dividend Date | | Dividend Payment | | | Market Capitalization | 0 | 1 Year Price-Target | 0.00 | | Note: The data may have some minutes of delay. |
|
News about Biogen Idec Inc. [BIIB]: (ordered by relevance)
| | Auto-Injectors Market 2022 Global Trend, Segmentation and Opportunities, Forecast 2030: Mylan, BD, Johnson & Johnson, Amgen Inc., Eli Lilly, Biogen Idec, Bayer ? Indian Defence News Indian Defence News
Orphan Drugs Market Size, Scope and Forecast | Celgene Corporation, Hoffmann- La Roche, Bristol-Myers Squibb, Alexion Pharmaceuticals, Inc., Biogen Idec Limited, Novartis AG, Vertex Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Limited ? D Designer Women
Neuropathic Pain Market Is Booming Worldwide 2022-2028 | Pfizer, Inc., Johnson & Johnson Services, Inc., Sanofi S.A., Eily Lily and Company, GlaxoSmithKline PLC, Biogen Idec Digital Journal
Recombinant Coagulation Factors Market 2022 Global Competition by Opportunity Assessment and Forecast by 2028: Baxter International, Bayer, Biogen Idec, CSL, Grifols International, Kedrion S.P.A. Digital Journal
Subcutaneous Biologics Market See Huge Growth for New Normal | Abbott Laboratories, Pfizer Inc., Genentech Inc. ? Designer Women Designer Women
In-depth Research on Cognition-Enhancing Drugs Market Forecast ? Estimation & Approach 2022-2028 | Accelerated Intelligence, Cognition Therapeutics, Cogstate, HVMN, Biogen Idec,, and more | Affluence ? Indian Defence News Indian Defence News
Global Gastric Cancer Testing, Treatment and Prevention Market 2022 Research Report Analysis ? Biogen Idec, Bristol Myers Squibb, Eli Lilly And Company, Glaxosmithkline Genentech Inc ? Designer Women Designer Women
Protein Drugs Market 2022 Key Players, Industry Overview, Supply Chain and Analysis to 2028 -Eli Lilly, Abbott Laboratories ? Designer Women Designer Women
Nephropathy Medicine Market Size, Status, Precise Outlook 2022 To 2028 | Shionogi Inc., Sanofi-aventis, Genzyme Corporation, Bayer ? Designer Women Designer Women
Multiple Sclerosis Ms Drugs Market is Likely to Expand at Promising CAGR with| Bayer AG, Bayhill Therapeutics, Biogen Idec ? Indian Defence News Indian Defence News
Antibody Drugs Market 2022 Top Key Players, Demands, Trends and Forecasts to 2030 ? Indian Defence News Indian Defence News
Will Biogen Stock Rise After The Recent 6% Fall? Forbes
Biologics Manufacturing Market 2022 Share, Growth Insights, Trends, and Forecast till 2030 ? Designer Women Designer Women
Oligonucleotide Synthesis Market Size Worth USD 9.91 Billion by 2027 | Emergen Research Study EIN News
Follow-On-Biologics Market 2022 Top Key Players, Demands, Trends and Forecasts to 2030 ? Indian Defence News Indian Defence News
Autoimmune Therapeutics Market Report 2022; In-depth Assessment, 4.2% Healthy CAGR, Significant Development, I openPR
Autoinjectors Market 2022 Top Key Players, Demands, Trends and Forecasts to 2030 ? Indian Defence News Indian Defence News
Kinase Inhibitors Market 2022 Top Key Players, Demands, Trends and Forecasts to 2030 ? Indian Defence News Indian Defence News
Acquired Hemophilia A Drug Treatment Market 2022 Top Key Players, Demands, Trends and Forecasts to 2030 ? Indian Defence News Indian Defence News
Biogen's roller coaster 2021 takes another surprising turn with report of $42B Samsung buyout interest FiercePharma
Biogen | Newsroom investors.biogen.com
Biogen Stock: Will This Second Bite At The Alzheimer's Apple Payoff? Investor's Business Daily
Cancer Antibody Drug Conjugates Market Trends Analysis,Top Manufacturers,Shares,Growth Opportunities,Statistic openPR
Biogen Idec: A Great Company, But Not An Alpha Opportunity (NASDAQ:BIIB) Seeking Alpha
Biogen Drops Idec From Name - WSJ The Wall Street Journal
Workable Strategic Report on Solid Tumors Treatment Market by Forecast to 2027 with Covered Top Companies like Abbott Laboratories Inc., Biogen Idec Incorporated, AstraZeneca Plc Medgadget
Here?s Why Biogen Stock Can Offer Over 35% Gains Forbes
Biogen Sells Bioepis Stake for $2.3 Billion to Samsung Biologics JD Supra
Alzheimer's drug from Biogen wins US approval Financial Times
Biogen Idec and Genentech Tweak Anti-CD20 Alliance to Prevent Future Squabbles Genetic Engineering & Biotechnology News
The Architect Of Biogen's Controversial Alzheimer's Strategy, Al Sandrock, To Retire Scrip
Subcutaneous Biologics Market will generate new growth opportunities 2022-2028 | Genentech, Biogen Idec, F. Hoffmann-La Roche AG Digital Journal
Movers & Shakers, March 11 | BioSpace BioSpace
BIIB Stock Forecast, Price & News (Biogen) MarketBeat
Biogen Idec (BIIB) shifts Machelle Sanders from head of RTP manufacturing to lead multiple sclerosis development - Triangle Business Journal The Business Journals
Biogen/Samsung Approval of BYOOVIZ? | Goodwin - JDSupra JD Supra
Biogen Idec's Strategy For Neurology RD Success Life Science Leader Magazine
Exclusive: Biogen prices hemophilia drug on par with older therapies Reuters.com
Interferon Beta Drugs Market Size Is Anticipated To Reach US$ 4,825.8 Million at a CAGR of 3.5% By 2027 | Biogen Idec., Merck KGaA, Novartis Pharmaceuticals Corporation, and Bayer. Medgadget
Biogen Idec provides coach commuting for suburban workers The Boston Globe
How Biogen Makes Money: Treatments for Neurological Disorders Investopedia
Could Vertex Pharmaceuticals Be a Prime Acquisition Target? The Motley Fool
Biogen to pay Forward Pharma $1.25 billion to protect MS drug Reuters.com
| For more news about Biogen Idec Inc. click here:
Biogen Idec Inc. News |
|
Website Width:
Background image: |
|  | |
|
|
